{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:18:31Z","timestamp":1777540711404,"version":"3.51.4"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Health","award":["DA07606"],"award-info":[{"award-number":["DA07606"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.neuropharm.2013.04.040","type":"journal-article","created":{"date-parts":[[2013,5,2]],"date-time":"2013-05-02T21:02:46Z","timestamp":1367528566000},"page":"96-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Cyclooxygenase activity contributes to the monoaminergic damage caused by serial exposure to stress and methamphetamine"],"prefix":"10.1016","volume":"72","author":[{"given":"Nicole A.","family":"Northrop","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan K.","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2013.04.040_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/jcbfm.2008.88","article-title":"The neuroprotective effect of prostaglandin E2 EP1 receptor inhibition has a wide therapeutic window, is sustained in time and is not sexually dimorphic","volume":"29","author":"Abe","year":"2009","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.prostaglandins.2009.04.003","article-title":"Emerging roles of PGE2 receptors in models of neurological disease","volume":"91","author":"Andreasson","year":"2010","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neulet.2003.08.015","article-title":"Methamphetamine-induced neurotoxicity in mouse brain is attenuated by ketoprofen, a non-steroidal anti-inflammatory drug","volume":"352","author":"Asanuma","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib4","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1523\/JNEUROSCI.22-06-02135.2002","article-title":"Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity","volume":"22","author":"Battaglia","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.nbd.2008.11.013","article-title":"Minocycline restores striatal tyrosine hydroxylase in GDNF heterozygous mice but not in methamphetamine-treated mice","volume":"33","author":"Boger","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib6","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0022-3565(25)11370-0","article-title":"The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum","volume":"260","author":"Bowyer","year":"1992","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/cne.903550208","article-title":"Characterization of inducible cyclooxygenase in rat brain","volume":"355","author":"Breder","year":"1995","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib8","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2174\/092986708785132915","article-title":"Therapeutic targets in prostaglandin E2 signaling for neurologic disease","volume":"15","author":"Cimino","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib9","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1523\/JNEUROSCI.0802-06.2006","article-title":"Stress increases vulnerability to inflammation in the rat prefrontal cortex","volume":"26","author":"de Pablos","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib10","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0028-3908(89)90130-5","article-title":"Methamphetamine-induced neuronal damage: a possible role for free radicals","volume":"28","author":"De Vito","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.04.040_bib11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.psyneuen.2009.10.001","article-title":"Serotonin 2 receptor modulation of hyperthermia, corticosterone, and hippocampal serotonin depletions following serial exposure to chronic stress and methamphetamine","volume":"35","author":"Doyle","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2013.04.040_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.eplepsyres.2010.06.012","article-title":"Targeting the prostaglandin E2 EP1 receptor and cyclooxygenase-2 in the amygdala kindling model in mice","volume":"91","author":"Fischborn","year":"2010","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brainres.2004.04.072","article-title":"Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine","volume":"1016","author":"Fukami","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejphar.2010.05.001","article-title":"Prostanoid EP1 receptor antagonist reduces blood-brain barrier leakage after cerebral ischemia","volume":"640","author":"Fukumoto","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib15","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.neubiorev.2008.04.001","article-title":"Stress as a neuroinflammatory condition in brain: damaging and protective mechanisms","volume":"32","author":"Garcia-Bueno","year":"2008","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib16","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1210\/en.2007-0482","article-title":"Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-activated receptor-gamma activation after stress in rats","volume":"149","author":"Garcia-Bueno","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2013.04.040_bib17","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1046\/j.1471-4159.1995.64041819.x","article-title":"Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine","volume":"64","author":"Giovanni","year":"1995","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nri1571","article-title":"Stress-induced immune dysfunction: implications for health","volume":"5","author":"Glaser","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib19","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.bcp.2006.04.011","article-title":"NF-kappaB activation by reactive oxygen species: fifteen years later","volume":"72","author":"Gloire","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1460-9568.2009.07059.x","article-title":"Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin","volume":"31","author":"Goncalves","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002130000650","article-title":"Chronic unpredictable stress, but not chronic predictable stress, enhances the sensitivity to the behavioral effects of cocaine in rats","volume":"154","author":"Haile","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2013.04.040_bib22","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1046\/j.1471-4159.1995.64020919.x","article-title":"Enzymatic oxidation of dopamine: the role of prostaglandin H synthase","volume":"64","author":"Hastings","year":"1995","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib23","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1046\/j.1471-4159.1994.63031126.x","article-title":"Identification of catechol-protein conjugates in neostriatal slices incubated with [3H]dopamine: impact of ascorbic acid and glutathione","volume":"63","author":"Hastings","year":"1994","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib24","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.neuroscience.2009.01.067","article-title":"Chronic unpredictable stress augments\u00a0+3,4-methylenedioxymethamphetamine-induced monoamine depletions: the role of corticosterone","volume":"159","author":"Johnson","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.04.040_bib25","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1124\/jpet.110.171322","article-title":"Chronic stress enhances the corticosterone response and neurotoxicity to\u00a0+3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperature","volume":"335","author":"Johnson","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neuint.2009.10.005","article-title":"Potentiation of methamphetamine neurotoxicity by intrastriatal lipopolysaccharide administration","volume":"56","author":"Jung","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nm1362","article-title":"Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity","volume":"12","author":"Kawano","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib28","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0028-3908(99)00175-6","article-title":"Methamphetamine-induced striatal dopamine neurotoxicity and cyclooxygenase-2 protein expression in BALB\/c mice","volume":"39","author":"Kita","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.04.040_bib29","doi-asserted-by":"crossref","first-page":"10923","DOI":"10.1523\/JNEUROSCI.19-24-10923.1999","article-title":"An essential role of interleukin-1beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia","volume":"19","author":"Laflamme","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.expneurol.2004.01.010","article-title":"Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity","volume":"187","author":"LaVoie","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib31","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1523\/JNEUROSCI.19-04-01484.1999","article-title":"Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine","volume":"19","author":"LaVoie","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib32","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1046\/j.1471-4159.1999.0732546.x","article-title":"Peroxynitrite- and nitrite-induced oxidation of dopamine: implications for nitric oxide in dopaminergic cell loss","volume":"73","author":"LaVoie","year":"1999","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12640-010-9223-x","article-title":"Methamphetamine causes persistent immune dysregulation: a cross-species, translational report","volume":"20","author":"Loftis","year":"2011","journal-title":"Neurotox Res."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib34","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/sj.npp.1300187","article-title":"Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain","volume":"28","author":"Madrigal","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2013.04.040_bib35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0893-133X(00)00208-6","article-title":"Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain","volume":"24","author":"Madrigal","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2013.04.040_bib36","doi-asserted-by":"crossref","first-page":"11449","DOI":"10.1523\/JNEUROSCI.3597-04.2004","article-title":"High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity","volume":"24","author":"Mark","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib37","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neuroscience.2003.12.007","article-title":"Chronic stress augments the long-term and acute effects of methamphetamine","volume":"124","author":"Matuszewich","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.04.040_bib38","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1196\/annals.1314.049","article-title":"Effects of chronic stress on methamphetamine-induced dopamine depletions in the striatum","volume":"1032","author":"Matuszewich","year":"2004","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib39","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0022-3565(24)39008-1","article-title":"Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia","volume":"295","author":"Metzger","year":"2000","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib40","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1096\/fj.05-4996fje","article-title":"Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone-formation-related molecules","volume":"20","author":"Miyazaki","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1749-6632.1997.tb51693.x","article-title":"The interaction between the central and peripheral nervous systems in mediating the thermic effect of methamphetaminea","volume":"813","author":"Mohaghegh","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib42","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/sj.jcbfm.9600106","article-title":"NFkappaB activates in\u00a0vivo the synthesis of inducible Cox-2 in the brain","volume":"25","author":"Nadjar","year":"2005","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib43","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jneuroim.2005.09.012","article-title":"Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation","volume":"171","author":"Nair","year":"2006","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib44","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0006-8993(92)90713-J","article-title":"Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine","volume":"581","author":"Nash","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib45","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1124\/jpet.110.177287","article-title":"Regulation of glutamate release by alpha7 nicotinic receptors: differential role in methamphetamine-induced damage to dopaminergic and serotonergic terminals","volume":"336","author":"Northrop","year":"2011","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib46","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s11481-012-9391-y","article-title":"Persistent neuroinflammatory effects of serial exposure to stress and methamphetamine on the blood-brain barrier","volume":"7","author":"Northrop","year":"2012","journal-title":"J.\u00a0Neuroimmune Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib47","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0006-8993(85)90153-2","article-title":"Long-term effects of repeated methylamphetamine administration on monoamine neurons in the rhesus monkey brain","volume":"338","author":"Preston","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.brainres.2006.12.002","article-title":"Effects of chronic unpredictable stress and methamphetamine on hippocampal glutamate function","volume":"1135","author":"Raudensky","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib49","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0006-8993(82)90198-6","article-title":"Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain","volume":"235","author":"Ricaurte","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib50","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib51","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0304-3940(80)90314-6","article-title":"Origin of dopaminergic innervation of the rat hippocampal formation","volume":"18","author":"Scatton","year":"1980","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: structural, cellular, and molecular biology","volume":"69","author":"Smith","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib53","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0022-3565(25)22956-1","article-title":"Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice","volume":"256","author":"Sonsalla","year":"1991","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib54","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bbi.2006.11.006","article-title":"An inflammatory review of glucocorticoid actions in the CNS","volume":"21","author":"Sorrells","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib55","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1471-4159.2005.03618.x","article-title":"Methamphetamine-induced spectrin proteolysis in the rat striatum","volume":"96","author":"Staszewski","year":"2006","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib56","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1046\/j.1471-4159.1994.63020596.x","article-title":"Physiological elevations of glucocorticoids potentiate glutamate accumulation in the hippocampus","volume":"63","author":"Stein-Behrens","year":"1994","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib57","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/syn.890170310","article-title":"Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux","volume":"17","author":"Stephans","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2013.04.040_bib58","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1460-9568.2007.05688.x","article-title":"Augmentation of methamphetamine-induced toxicity in the rat striatum by unpredictable stress: contribution of enhanced hyperthermia","volume":"26","author":"Tata","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib59","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/syn.20497","article-title":"Chronic stress enhances methamphetamine-induced extracellular glutamate and excitotoxicity in the rat striatum","volume":"62","author":"Tata","year":"2008","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2013.04.040_bib60","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neulet.2004.06.065","article-title":"Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines","volume":"367","author":"Thomas","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.104.070961","article-title":"Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation","volume":"311","author":"Thomas","year":"2004","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib61","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1124\/jpet.104.080242","article-title":"Cyclooxygenase-2 is an obligatory factor in\u00a0methamphetamine-induced neurotoxicity","volume":"313","author":"Thomas","year":"2005","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib62","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.brainres.2005.05.049","article-title":"MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity","volume":"1050","author":"Thomas","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib64","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1021\/jm00223a008","article-title":"Potential oxidative pathways of brain catecholamines","volume":"19","author":"Tse","year":"1976","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib65","first-page":"221","article-title":"Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats","volume":"47","author":"Wagner","year":"1985","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib66","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0006-8993(80)91265-2","article-title":"Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites\u00a0following repeated administration of methamphetamine","volume":"181","author":"Wagner","year":"1980","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib67","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0006-8993(89)91279-1","article-title":"Long-term effects of chronic methamphetamine administration in rhesus monkeys","volume":"486","author":"Woolverton","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib68","doi-asserted-by":"crossref","first-page":"7838","DOI":"10.1523\/JNEUROSCI.20-20-07838.2000","article-title":"Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity","volume":"20","author":"Xie","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib69","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0896-6273(93)90192-T","article-title":"Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids","volume":"11","author":"Yamagata","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2013.04.040_bib70","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.neuroscience.2010.07.051","article-title":"Cyclooxygenase and nitric oxide synthase in the presympathetic neurons in the paraventricular hypothalamic nucleus are involved in restraint stress-induced sympathetic activation in rats","volume":"170","author":"Yamaguchi","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.04.040_bib71","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-3565(24)37769-9","article-title":"The effects of methamphetamine on the production of free radicals and oxidative stress","volume":"287","author":"Yamamoto","year":"1998","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib72","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2174\/138161208784480144","article-title":"Cyclooxygenase-2 in synaptic signaling","volume":"14","author":"Yang","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib73","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1471-4159.2010.06839.x","article-title":"Dopamine is not essential for the development of methamphetamine-induced neurotoxicity","volume":"114","author":"Yuan","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.04.040_bib74","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.neuroscience.2007.09.059","article-title":"Selective inhibition of cyclooxygenase-2 exacerbates methamphetamine-induced dopamine depletion in the striatum in rats","volume":"150","author":"Zhang","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.04.040_bib75","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1210\/endo.133.6.8243274","article-title":"Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis","volume":"133","author":"Zhou","year":"1993","journal-title":"Endocrinology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081300186X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081300186X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T08:05:09Z","timestamp":1746000309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081300186X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":75,"alternative-id":["S002839081300186X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.04.040","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclooxygenase activity contributes to the monoaminergic damage caused by serial exposure to stress and methamphetamine","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.04.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}